Ipamorelin 10mg / Tesamorelin 10mg Blend

This blend combines Ipamorelin and Tesamorelin, two peptides studied for their roles in growth hormone–releasing signaling pathways and metabolic regulation, without supplying exogenous growth hormone.
 
Ipamorelin is a selective growth hormone secretagogue explored in research settings for its targeted receptor activity and minimal interaction with cortisol or prolactin pathways.
Tesamorelin is a growth hormone–releasing hormone (GHRH) analogue studied for its involvement in metabolic signaling and body composition–related pathways, particularly in abdominal fat metabolism research contexts.
 
Together, this formulation is of interest in advanced research environments focused on endogenous growth hormone pulsatility, metabolic efficiency signaling, recovery pathways, and sleep-related hormone rhythms.
 
This product is supplied in lyophilized form and is intended for research and professional use only, under appropriate clinical oversight.
 
Key Characteristics:
 
Dual-peptide blend targeting growth hormone–releasing pathways
Designed to support natural, pulsatile hormone signaling
Studied for metabolic, recovery, and body composition-related pathways
Does not provide exogenous growth hormone
Supplied in lyophilized form
 
Important Notice:
This product is not intended to diagnose, treat, cure, or prevent any disease. Intended for use by qualified professionals in accordance with applicable regulations.